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Abstract— The noval method for mutational disease prediction using bioinformatics tools and datasets for diagnosis the malignant 
mutations with powerful Artificial Neural Network (Backpropagation Network) for classifying these malignant mutations are related to 
gene(s) (e.g. BRCA1 and BRCA2) cause a disease (breast cancer). This noval method didn’t take  in consideration just  like adopted for 
dealing, analyzing and treat the gene sequences for extracting useful information from the sequence, also exceeded the environment 
factors which  play important roles in deciding and calculating some of genes features in order to view its functional parts and relations to 
diseases. This paper is proposed an enhancement of a novel method as a first way for diagnosis and prediction the disease by mutations 
considering and introducing multi other features show the alternations, changes in the environment as well as genes, comparing 
sequences to gain information about the structure/function of a query sequence, also proposing optimal and more accurate system for 
classification and dealing with specific disorder using backpropagation with mean square rate 0.000000001. 
Index Terms— Homology sequence, GC% content & AT% content, Bioinformatics, Backpropagation Network, BLAST, DNA Sequence, 
Protein Sequence 
——————————      —————————— 
1 INTRODUCTION                                                                     
ANCER  is a dynamic disease, it has been estimated that 
a new genetic alteration occurs in one out of 10000 tumor 
cells at each cell division. This leads to an increasing 
number of genetic aberrations in cancer cells, some of which 
result in altered gene expression. These changes in gene ex-
pression are at least partially responsible for the characteristic 
of a tumor or tumor-type. Genome-wide gene expression pro-
files provide detailed “tumor signatures” and can potentially 
be used for molecular diagnosis and classification of tumors 
[1].  Cancer is a complex family of diseases, from the view of 
molecular biology; cancer is a genetic disease resulting from 
abnormal gene expression. This alternation of gene expression 
could be resulting from DNA instability, such as translocation, 
amplification, deletion or point mutations [2]. Breast cancer 
remains  the  most  frequently  diagnosed  and the  second 
most lethal cancer  for  women  in  the  world[3] 
 
The diagnosis and prediction of the cancer are important 
measures to avoid this disease specially for those which they 
have in their family [4], and that represented in novel method 
for mutational disease prediction as shown in Fig. 1, this noval 
method based on two approaches the first for diagnosis nucle-
otide and its protein mutations through bioinformatics tools. 
And the second classify gene mutations (that have been diag-
nosed) are related to breast cancer or other cancer tissues us-
ing backpropagation neural network [9].  
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Important of Genome/Gene sequence in obtaining a blue-
print–DNA directs all the instructions needed for cell devel-
opment and function, DNA underlies almost every aspect of 
human health, in function and disfunction, to study gene ex-
pression in a specific tissue, organ or tumor, to study human 
variation, studying how humans relate to other organisms,  
finding correlations how genome information relates to devel-
opment of cancer, susceptibility to certain diseases and drug 
metabolism is great challenge with providing tools for view-
ing, analyzing, discovering features and genes properties [5].  
C 
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Fig. 1. Flowchart for main tasks of a novel method [9] 
.  
 
  
GC content is different in genes compared to the whole ge-
nome. In genes, the GC content is centered a round to 45-50%, 
and it is more uniformly distributed than in the genome. The 
genome is mostly 38% GC with its distribution skewed to the 
left. As a consequence, regions of high GC content (62-68%) 
have higher relative gene density than regions of lower GC 
content [6]. And also Mutator genes, especially those with 
dominant effects on the mutation spectra, are biased towards 
either GC or AT richness [7].  
 
Homology search through The BLAST program works on 
the principle that regions of similarity are likely to contain 
strongly conserved, indel-resistant segments. These areas of 
strong conservation show up as non-gapped blocks in an 
alignment. Recent versions are also capable of producing 
gapped alignments, but they still build these gapped align-
ments up from non-gapped segments. This means that BLAST 
is most likely to fail to detect a homologous sequence where 
indels are scattered liberally and regularly throughout: in oth-
er words, highly divergent sequences may be missed. In a 
pairwise search, a query sequence is compared to a database 
sequence, yielding a score that indicates the likelihood of ho-
mology. This comparison is repeated for every sequence in the 
database and high-scoring hits are reported [8]. 
 
So there is multi features the noval method for mutational 
disease prediction must be taken in consideration like adopted 
for dealing, analyzing and treat the gene sequences for extract-
ing useful information from the sequence, also the environ-
ment factor play important roles in deciding and calculating 
some of genes features in order to view its functional part and 
relations to diseases. By using bioinformatics tools and da-
tasets with powerful Artificial Neural Network ANN (Back-
Porpagation Network BPN) structure can make improve-
ment/enhancement of a novel method. 
2 RELATED WORK 
Ayad Ghany Ismaeel, Anar A. Ablahad [9] developed a novel 
method for disease mutation prediction and classification 
based on two approaches which are first: diagnosis nucleotide 
and its protein mutations through bioinformatics tools (fasta, 
BioEdit and ClustalW). And second:  classifying (BRCA1 and 
BRCA2) gene mutations whether these mutations (malignant) 
related to breast cancer or other cancer tissues using 
backpropagation neural network. The result of the paper 
showed reliable and accurate results with actual results of mu-
tations diagnosis and classification. 
 
Novel method reached to predict completely and obtained 
best results but there are some points not taken into considera-
tion although are important for this noval method. Like the 
dataset adopted in the method and the normal gene used for 
comparison, also gene sequence analysis and gene features 
which play important roles in dealing and dis-covering gene 
actions and abilities. 
 
 
 
 
The motivation overcome the drawbacks to reach an en-
hancement of a novel method, considering and introducing 
multi other features show the alternations, changes in the en-
vironment as well as genes,  comparing sequences to gain in-
formation about the structure/function of a query sequence, 
also proposing optimal and more accurate system for classifi-
cation and dealing with specific disorder. 
3 PROPOSED AN ENHANCEMENT OF A NOVEL METHOD 
The collection datasets relate to gene caused a disease is very 
important stage in the proposed of enhancement a noval 
method, because the noval method didn't care about it, how-
ever as show it can play an important role for mutational dis-
ease predication, as referring to section 1. 
  
This proposal of enhancement a noval method focus on the 
important feature in Bioinformatics tools which is BLAST to 
reach to best Homology sequence related to the environment 
which is different from region to another.  
 
The algorithm of main tasks for enhancement a novel 
method of maturational disease prediction, which based on 
overcome the drawbacks at novel method [9], this enhance-
ment will refer to it in red as follow: 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Algorithm of main tasks for Enhancement a Novel method 
 
Input: DNA sequence (normal and person’s gene sequence) 
Output: Classification of tumor gene mutations (for the patient) 
   
BEGIN 
   Step 1: collect datasets for the project 
   Step 2: search normal Homology Sequences at BLAST 
   Step 3: calculate GC% and AT% 
   Step 4: Find the percentage of normal gene homology e.g. at NCBI  
   Step 5: if GC% satisfies 38% then 
                    Depend it 
             Else find another normal Homology seguence form another  
                     Database like EBI, Ensemble, etc and return to step 2 
Step 6: Get normal gene sequences 
 Step 7: CREATE fasta file;  
           SET normal and Person’s gene sequence to fasta file 
   Step8: SET fasta file to clustalW for alignment; Display alignment result 
   Step9: Simulate ANN (BPN) of optimal (new) structure. 
   Step10: CREATE training dataset file of Breast cancer mutations 
               Input DNA gene sequence (of the patient); 
               Display BPN results; 
               If matching found then 
                   Display”highly risk of breast  cancer” 
               Else Disply no risk "Normal" 
END 
 
  
4 EXPERIMENTAL RESULTS 
4.1 Bioinformatics Techniques 
Implement the proposed enhancement of noval method will 
apply to diagnosis the mutations at patient gene and its pro-
tein is malignant or not.   
In order to know how to access and get helpful bioinfor-
matics tools this modified approach to reach an enhancement 
of a novel method consider the collection dataset related to 
gene caused the disease is very important stage in the pro-
posed of enhancement a noval method, because the noval 
method which not care about it for mutational disease predi-
cation, so in this stage will consider additional parts as follow: 
 
1. The data set adapted to depend on the environment, 
as it plays roles in alternations and differences in 
genes shapes also genes mutations. 
2. The researchers or biologists adopt a normal gene for 
analysis and comparison should be compatible with 
the environment of the study. The improvement of 
this point can be shown in Fig. 2. The normal gene 
can be obtained from NCBI or EBI, Ensemble, COS-
MIC. and each of these databases provide different 
form of normal gene adopted in the local database 
but when search for homology sequences at NCBI, 
the 100% match found between the two normal gene 
sequences. When normal gene of COSMIC is entered 
to NCBI at blast it shows the RefSeq (normal) as the 
first one in homology list with max identities=100. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Calculating  GC%content and AT% content for gene 
stability and ability of doing amplification can be 
done by using BioEdit package to determine ratios 
and some amino acid and protein features. Needed to 
calculate GC% and AT% of normal BRCA1 gene to 
determine is the genome around 38% GC to depend 
it otherwise search about another normal BRCA1 
gene form another database, shown in Fig. 3, Fig. 4 
and Fig. 5 respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
When reaching to this stage will need to complete another 
important bioinformatics tool which is ClustalW, that tool can 
work with fasta file for diagnosis there are malignant muta-
tions or not, as referring to it in noval method [9]. 
 
4.2 Backpropagation Algorithm 
To predict these malignant mutations which obtained in sub-
section 4.1 (using bioinformatics tools) are related to BRCA1 
and BRCA2 (which caused breast cancer) based on noval 
method need training the BPN by all malignant mutations 
(which are 5 related to BRCA1 and 4 related to BRCA2) then 
used to classify these malignant mutations which caused 
breast cancer [9]. 
 
 
Fig. 2. Adopt a normal gene for analysis and comparison. 
 
 
Fig. 3. Gene bases positions. 
 
 
Fig. 4.  Gene ratios of A, G ,T and C. 
 
 
Fig. 5. Calculating GC% and AT% 
.  
 
  
 
The new modification in the BPN, i.e. get a new structure 
which can be summarized as the optimum and accurate result 
with best performance comparing to the previous novel meth-
od, the BPN is  most commonly used in medical research. 
BPNs where the signals travel in one direction from input 
neuron to an output neuron without returning to its source, 
neural network is a sorted topology which include node and 
weighted connections. Each layer inside neural network will 
be connected by their weight connector; the new BPN consists 
of (input layer, at least one hidden layer and output layer) as 
shown in Fig. 6 [6]. 
 
 
 
 
 
 
 
 
 
 
 
 
That means the enhancement of a novel method will be 
used a feed forward back-propagation network as popular 
model in neural network, the new structure of BPN consist of:  
1. One input layer with 10 nodes at the input layer 
2. One hidden layer with 4 nodes at hidden layer  
3. One output layer with one node at the output layer. 
 
Using MATLAB R2010a on PC type Core i3 for neural 
network toolbox because it contains various functions the clas-
sification of malignant mutations for breast cancer was devel-
oped successfully using new structure of feed-forward BP 
neural network to obtain an optimal classifier for prediction a 
breast cancer or any other disease with mean square error 
0.000000001, as shown in Fig. 7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8 reveals plot of the important element of training new 
structure of feed-forward BPN, which is the plot of perfor-
mance.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3 Discussion the Results 
Table 1 reveals comparing the results of implementing an en-
hancement of a novel method with the noval method (the 
origin) for mutational disease prediction [9].  
TABLE 1 
REVEALS COMPARISON AN ENHANCEMENT OF A NOVEL 
METHOD WITH NOVEL METHOD FOR MUTATIONAL DISEASE 
PREDICTION 
        
             The Feature 
Enancement 
of a Novel 
Method 
Novel Method 
(the  origin )[9] 
Datasets adopted is de-
pended of the environ-
ment, as it play roles in 
alternations and differences 
in genes shapes and genes 
mutations. 
Yes No 
Normal gene can be ob-
tained different form 
adopted to the local data-
base (based on their  envi-
ronment)  
Yes  No 
Considered the  GC% con-
tent and AT% content for 
gene 
Yes No 
Mean square rate. Mean square 
rate 
0.000000001 
Mean square 
rate 0.0000001 
 
Optimize the classifying 
BPN. 
 
Yes 
 
No 
 
Fig. 6 New structre of BPN  
 
 
Fig. 7. Training a new structure of feed-forward BPN 
.  
 
 
Fig. 8. Plot performance of trainng a new structure of BPN 
.  
 
  
5 CONCLUSTIONS  
The important conclusions which obtained from implement-
ing the proposed enhancement of novel method for mutation-
al disease prediction are: 
 
1. The enhancement of a novel method will base on col-
lection datasets which related to environment, so that 
means the results of diagnosis using bioinformatics 
tools and then the classifying of BPN, i.e. the predic-
tion is more expressive for the region and will be bet-
ter as this as have seen from the above impact on the 
results and how it could affect the environment. 
 
2. This enhancement of a novel method based on calcu-
lating the GC% content and AT% content for selecting 
the a normal gene caused the disease and make 
GC%= 38% as measure to depend the normal Homol-
ogy sequence which is playing important role to select 
the appropriate normal Homology sequence related 
to environment.  
 
3. Offers an automatic and friendly diagnosis system for 
detecting malignant mutation and pre-predict of 
breast cancer as shown in Table 1, i.e. can use by any 
researcher or patient who needed to test malignant 
mutations at gene(s) which caused any cancer known 
its malignant mutations. 
 
4. This Enhancement model of classification malignant 
mutations for breast cancer was developed successful-
ly using new structure of feed-forward back-
propagation neural network, i.e. obtained a best clas-
sifier for prediction a breast cancer or any other dis-
ease disease known its malignant mutations with 
mean square error 0.000000001. 
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